Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
134,259
|
205,604
|
104,577
|
84,470
| Cost of Revenue | 154,731 | 194,741 | 108,650 | 53,443 | |
Gross Profit
|
(20,472)
|
10,863
|
(4,073)
|
31,027
| |
|
Operating Expenses |
|
Research Development | 9,168 | 8,929 | 9,699 |
-
|
|
Selling General and Administrative | 35,365 | 32,542 | 34,093 | 31,465 |
|
Non Recurring | 270,140 |
-
|
-
|
-
|
|
Others | 9,854 | 9,724 | 2,530 | 107 |
|
|
|
Total Operating Expenses | 324,527 |
-
|
-
|
-
| | |
Operating Income or Loss
|
(344,999)
|
(40,332)
|
(50,395)
|
(545)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 965 | 1,852 | (33,769) | (4,974) |
|
Earnings Before Interest And Taxes | (366,150) | (28,760) | (93,969) | (5,434) |
|
Interest Expense | (14,989) | 14,989 |
-
|
-
|
|
Income Before Tax | (351,161) | (43,749) | (93,969) | (5,434) |
|
Income Tax Expense | 4,367 | (28,957) | (27,302) | (2,183) |
|
Minority Interest | (1,706) | (3,440) |
-
|
-
|
|
|
|
Net Income From Continuing Ops | (359,578) | (18,894) | (67,604) | (3,478) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
(359,578)
|
(18,894)
|
(67,604)
|
(3,478)
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
(359,578)
|
(18,894)
|
(67,604)
|
(3,478)
|
|